指南与共识姑息放疗与转移瘤放疗物理与技术

ESTRO临床实践指南:脊柱转移瘤的立体定向体部放疗

ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases.
指南 / 共识 · Radiother Oncol · 2023-11-02

该ESTRO临床实践指南基于PRISMA标准系统文献综述,围绕脊柱转移瘤SBRT适应证与实践的四个关键问题形成22条推荐和5项声明,专家共识度均至少75%。多数推荐和声明的证据水平仅为中等或专家意见,提示脊柱SBRT仍属发展中临床研究领域。

要点

  • 针对疼痛性脊柱转移瘤及寡转移性疾病患者的筛选提出推荐。
  • 脊柱SBRT实践推荐涵盖剂量与分割、体位固定及图像引导实施等技术规划。
  • 制定质量保证方案推荐,包括潜在SBRT相关毒性描述与风险缓解策略。

核心结论

  • 该ESTRO临床实践指南提供关于脊柱转移瘤患者SBRT选择及其安全实施与操作的循证推荐和声明。
  • 作者认为将患者纳入设计良好、针对临床相关问题的前瞻性临床试验很重要。

研究设计与样本

  • 本ESTRO临床实践指南基于按PRISMA标准进行的系统文献综述,该综述构成回答四个关于脊柱转移瘤SBRT适应证与实践关键问题的基础。

主要发现

  • 基于当前证据对关键问题的分析产生22条推荐和5项声明,认可程度不一,均获得专家至少75%的共识。

关键数值与推荐

  • 多数支持推荐和声明的证据水平仅为中等或专家意见。
  • 推荐涉及合适疼痛性脊柱转移瘤及寡转移性疾病患者的选择。
  • 脊柱SBRT实践推荐涵盖技术规划方面,包括剂量与分割、患者体位、固定和图像引导SBRT实施。
  • 推荐涉及质量保证方案,包括潜在SBRT相关毒性描述和风险缓解策略。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数支持推荐和声明的证据水平仅为中等或专家意见,提示脊柱SBRT仍属发展中临床研究领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Recent progress in diagnostics and treatment of metastatic cancer patients have improved survival substantially. These developments also affect local therapies, with treatment aims shifting from short-term palliation to long-term symptom or disease control. There is consequently a need to better define the value of stereotactic body radiotherapy (SBRT) for the treatment of spinal metastases. METHODS: This ESTRO clinical practice guideline is based on a systematic literature review conducted according to PRISMA standards, which formed the basis for answering four key questions about the indication and practice of SBRT for spine metastases. RESULTS: The analysis of the key questions based on current evidence yielded 22 recommendations and 5 statements with varying levels of endorsement, all achieving a consensus among experts of at least 75%. In the majority, the level of evidence supporting the recommendations and statements was moderate or expert opinion, only, indicating that spine SBRT is still an evolving field of clinical research. Recommendations were established concerning the selection of appropriate patients with painful spine metastases and oligometastatic disease. Recommendations about the practice of spinal SBRT covered technical planning aspects including dose and fractionation, patient positioning, immobilization and image-guided SBRT delivery. Finally, recommendations were developed regarding quality assurance protocols, including description of potential SBRT-related toxicity and risk mitigation strategies. CONCLUSIONS: This ESTRO clinical practice guideline provides evidence-based recommendations and statements regarding the selection of patients with spinal metastases for SBRT and its safe implementation and practice. Enrollment of patients into well-designed prospective clinical trials addressing clinically relevant questions is considered important.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Guckenberger M, Andratschke N, Belka C, et al. ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases. Radiother Oncol. 2023. PMID: 37925107. doi:10.1016/j.radonc.2023.109966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。